Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome by Parisotto, Eduardo B. et al.
1 
 
Chronic melatonin administration reduced oxidative damage and 




Eduardo B. Parisottoa, Verónica Vidalb, Susana García-Cerrob, Sara Lantiguab, Danilo W. Filhoa, 
Emilio J. Sanchez-Barcelób, Carmen Martínez-Cuéb, Noemí Ruedab*. 
a Department of Ecology and Zoology, Federal University of Santa Catarina, Florianópolis, Brasil 
b Department of Physiology and Pharmacology, School of Medicine, University of Cantabria, 
39011 Santander, Spain 
*Corresponding author:  
Noemí Rueda 
Laboratory of Neurobiology of Learning 
Department of Physiology and Pharmacology 
Faculty of Medicine 
University of Cantabria 










Manuscript Click here to download Manuscript renamed_cd672.doc 





































































Previous studies have demonstrated that melatonin administration improves spatial learning and 
memory and hippocampal long-term potentiation in the adult Ts65Dn (TS) mouse, a model of 
Down syndrome (DS). This functional benefit of melatonin was accompanied by protection from 
cholinergic neurodegeneration and the attenuation of several hippocampal neuromorphological 
alterations in TS mice. Because oxidative stress contributes to the progression of cognitive 
deficits and neurodegeneration in DS, this study evaluates the antioxidant effects of melatonin in 
the brains of TS mice. Melatonin was administered to TS and control mice from 6 to 12 months of 
age and its effects on the oxidative state and levels of cellular senescence were evaluated. 
Melatonin treatment induced antioxidant and antiaging effects in the hippocampus of adult TS 
mice. Although melatonin administration did not regulate the activities of the main antioxidant 
enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and 
glutathioneS-transferase) in the cortex or hippocampus, melatonin decreased protein and lipid 
oxidative damage by reducing the thiobarbituric acid reactive substances (TBARS) and protein 
carbonyls (PC) levels in the TS hippocampus due to its ability to act as a free radical scavenger. 
Consistent with this reduction in oxidative stress, melatonin also decreased hippocampal 
senescence in TS animals by normalizing the density of senescence-associated β-galactosidase 
positive cells in the hippocampus. These results showed that this treatment attenuated the 
oxidative damage and cellular senescence in the brain of TS mice and support the use of 
melatonin as a potential therapeutic agent for age-related cognitive deficits and 
neurodegeneration in adults with DS. 






































































Down syndrome (DS) is characterized by a triplication of a complete or partial copy of 
chromosome 21 (Hsa21). The cognitive impairment of DS individuals is partially due to 
developmental alterations, although in later life stages, this impairment is progressively 
aggravated due to accelerated aging and the development of Alzheimer’s disease (AD) 
neuropathology [1, 2].  
Among the different mouse models of DS, the Ts65Dn (TS) mouse, that contains three copies of 
92 genes orthologous to Hsa21 genes [3], recapitulate numerous phenotypic characteristics of 
DS, including cognitive deficits and alterations in brain morphology and function [1, 4], that 
become more pronounced as the animals age [5]. 
One of the mechanisms that contributes to the accelerated aging, cognitive and neuronal 
dysfunction in DS is increased oxidative stress that is present from early life stages affecting 
neurogenesis and differentiation, connection and survival [6-8]. During later life stages, oxidative 
stress is aggravated in DS and in the TS mouse [9-12] contributing to their progression of 
cognitive and neuronal degeneration [4, 9,13].  
The enhanced oxidative stress found in DS individuals and in the TS mouse is caused by the 
triplication of several Hsa21 genes [9] including the SOD1/Sod1, the gene responsible for the 
formation of superoxide dismutase (SOD), which catalyzes the conversion of superoxide anions 
into hydrogen peroxide (H2O2). The increase in SOD activity results in the formation of 
disproportionate levels of H2O2, leading to the overproduction of highly reactive oxygen species 
(ROS). In addition, oxidative stress induces cell senescence [14, 15], a process that is 
characterized by permanent arrest of cell proliferation [16].  
Melatonin is an indoleamine mainly synthesized and secreted by the pineal gland. Its production 
progressively decreases as animals age [17], and its exogenous administration has been 




































































stress regulating anti- and pro-oxidant enzymes, acting as a potent ROS scavenger [21] and 
repairing molecules damaged by ROS overgeneration. Thus, melatonin has been proposed to be 
a powerful tool in the treatment of neuropathologies in which oxidative stress is enhanced. 
Our previous studies [10, 22], showed that melatonin treatment during adulthood improved spatial 
memory and hippocampal long-term potentiation (LTP) in TS mice. This functional benefit was 
associated with protection against cholinergic neurodegeneration and the normalization or 
attenuation of several hippocampal neuromorphological alterations of TS mice. The aim of this 
study was to evaluate the oxidative status and the density of senescent cells in the brain of adult 




































































Materials and methods 
Animals and housing 
This study was approved by the Cantabria University Institutional Laboratory Animal Care and 
Use Committee and was carried out in accordance with the Declaration of Helsinki and the 
European Communities Council Directive (86/609/EEC). Mice were generated, karyotyped, 
housed and maintained as previously described Corrales et al. [22].  
Melatonin treatment and experimental groups 
TS and euploid littermates (CO) mice were orally treated with melatonin (Mel: 100 mg/L; Sigma-
Aldrich, Madrid, Spain) or its diluent from 6 to 12 months of age as previously described Corrales 
et al. [10] and assigned to one of the following experimental groups: TS-Mel, CO-Mel, TS-vehicle 
or CO-vehicle. Six animals per group were used to assess the effects of melatonin administration 
on the oxidative stress assessments, while 7 extra animals per group were used to perform the 
senescence study.  
Oxidative stress assays 
Sample preparation. Cortex and hippocampal samples were homogenized in cold buffer 
containing 20 mM sodium phosphate, pH 7.4; 0.1 % Triton; and 150 mM NaCl (1:20 w/v) and 
centrifuged at 5000 g for 5 min. The supernatant was used to perform all the biochemical 
determinations that were carried out in triplicates. 
Antioxidant enzyme assays. Enzymatic activities were measured as described by Parisotto et al. 
[23]. Briefly, CAT activity was analyzed at 240 nm quantifying the decrease in the level of H2O2 
(expressed in mmol/min/g) in a 10 mM H2O2 solution. In order to determine SOD activity, the 
oxidation of epinephrine (pH 2.0 to pH 10.2), which produces superoxide anion and a pink 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Histochemical detection of senescence-associated β-galactosidase. To estimate the density of 
senescent cells in the SGZ of the dentate gyrus (DG) in the different groups of mice we used the 
SA-β-gal assay (senescence-associated β-galactosidase) method described by He et al. [25]. 
The hippocampal sections were washed twice with PBS and fixed for 15 min at room temperature 
with a 0.5 % glutaraldehyde solution. Next, the sections were washed and incubated with a 
staining solution containing 5-bromo-4chloro-3-indolyl-β-D-galactopyranoside (X-gal, 
Thermofisher Scientific, MA, USA) for 24 h at 37°C, mounted on Superfrost plus glass slides, 
dehydrated, cleared, and coverslipped with mounting medium. The density of SA-β-gal- positive 
cells (showing a blue reaction product over the cell soma) was determined by counting all blue 
cells in the SGZ of the DG of each animal using a Zeiss Axioskop 2 plus microscope with a 40X 
objective and dividing this number by the SGZ area. 
Statistical analysis 
Data were analyzed using MANOVA (‘genotype’ x ‘treatment’) followed by post-hoc group 
comparisons after Bonferroni corrections when all groups were compared and Student’s t-test 
when two individual groups were compared. All of the analyses were performed in SPSS (version 




































































To determine the brain oxidative stress status of adult TS mice and the possible beneficial effects 
of chronic administration of melatonin, we evaluated the levels of brain oxidative damage and the 
state of the antioxidant enzymatic system in the hippocampus and cortex of vehicle- and 
melatonin-treated TS and CO mice. Table 1 shows the results of the multivariance analysis on 
each variable assessed. 
Table 1. F values of MANOVA (genotype x treatment) for oxidative stress markers and 
antioxidant enzymatic activities in the cortex and hippocampus of the four groups of animals. 
MANOVA F(1,21) 
CORTEX HIPPOCAMPUS 
Genotype Treatment Genotype x 
Treatment 
Genotype Treatment Genotype x 
Treatment 
PC level 0.21, p=0.65 1.07, p=0.32 1.18, p=0.29 4.20, p=0.063 22.81, p<0.001 2.60, p=0.13 
TBARS level 1.30, p=0.27 2.92, p=0.10 0.18, p=0.67 0.01, p=0.89 9.52, p=0.008 1.42, p=0.25 
SOD activity 33.71, 
p<0.001 
0.001, p=0.97 1.33, p=0.26 0.33, p=0.571 0.046, p=0.83 1.18, p=0.29 
CAT activity 9.46, p=0.08 0.002, p=0.96 0.46, p=0.50 0.75, p=0.39 0.008, p=0.92 5.97, p=0.02 
GPx activity 4.85, p=0.04 0.11, p=0.74 1.09, p=0.31 12.13, p=0.003 1.02, p=0.32 0.40, p=0.53 
GR activity 0.009, p=0.92 0.13, p=0.71 0.12, p=0.72 0.021, p=0.88 0.78, p=0.38 0.50, p=0.48 
GST activity 1.57, p=0.22 0.008, p=0.93 3.33, p=0.08 8.51, p=0.01 1.02, p=0.32 1.40, p=0.25 
To evaluated the effects of melatonin treatment on the levels of brain oxidative damage, we 
measured the levels of PC (a marker of protein damage induced by ROS) and of TBARS (a 
marker of lipid damage induced by ROS or lipid peroxidation). 
Although MANOVA revealed no significant differences due to the genotype, post hoc analyses 
showed a significant increase in the level of oxidized proteins (PC, ~10%; t=2.48; p=0.038; Fig. 



































































hippocampus of adult vehicle-treated TS mice compared to CO mice under the same treatment. 
However, no differences in the cortical levels of both markers were observed between the 
different groups of animals (Fig. 1A and B). Melatonin significantly decreased the levels of protein 
damage (~12%; t=5.86; p=0.001) and lipid peroxidation (~29%; t=5.14; p<0.001) in the 
hippocampus of TS mice (Fig. 1A and B, Table 1) and produced a significant decrease in the 
levels of PC in the hippocampus of CO mice (~10%; t=2.68; p=0.028; Fig 1A, Table 1). 
Next, we examined whether melatonin might also exert its antioxidant effects by regulating the 
activity of the most important antioxidant enzymes in the cortex and hippocampus of the animals. 
As expected, SOD activity was increased (~143%) in the cortex of TS mice treated with vehicle 
compared to their CO littermates (Fig. 2A, Table 1). In the hippocampus, although MANOVA 
revealed the absence of significant differences due to genotype, post hoc comparisons showed 
higher SOD activity in vehicle-treated TS mice than in CO mice (~33%) under the same treatment 
(t=2.31; p=0.046). Melatonin administration did not modify SOD activity in either brain region 
(Table 1). 
We then analyzed the activity of CAT and GPx because the activity of SOD must be coordinated 
with the activity of these two antioxidant enzymes to metabolize the H2O2 that is produced by 
SOD into H2O and O2. As shown in Fig. 2B, CAT activity was increased in the cortex (~64%) but 
not in the hippocampus of TS animals. In addition, GPx activity was increased in both brain 
structures (cortex: ~34%; hippocampus ~27%, Fig. 2C) in vehicle-treated TS mice when 
compared to CO animals (Table 1). Chronic melatonin administration did not modify the activity of 
CAT or GPx in the cortex or hippocampus of TS or CO mice (Figs. 2B and C, Table 1). 
To detoxify hydroperoxides, GPx requires the participation of glutathione (GSH) as a co-factor to 
counteract the continuous formation of its oxidized form (GSSG), which is very toxic to cells. 



































































back into GSH. GR activity did not differ in the cortex or hippocampus of TS or CO mice that were 
treated with melatonin or vehicle during adulthood (Fig. 2D, Table 1). 
Finally, we measured the activity of GST, an enzyme that participates in the detoxification of the 
endogenous hydroperoxides continuously generated through cellular lipoperoxidation processes. 
TS mice presented less hippocampal GST activity (~12%) than CO mice that received the same 
treatment. However, GST activity was similar in the cortex of the different groups of mice (Fig. 2E, 
Table 1). 
Because oxidative stress induces premature cellular senescence, we assessed the density of SA-
β-gal-positive cells in the hippocampus of the four groups of mice. TS mice treated with vehicle 
presented a higher density of β-gal-positive cells than CO mice, indicating greater hippocampal 
senescence (MANOVA `genotype´: F(1,25)=6.35, p=0.019; Fig. 3). Interestingly, melatonin 
treatment significantly reduced the density of cells with a senescent phenotype in the DG of TS 




































































We have previously demonstrated that melatonin exerts cognitive-enhancing effects in the adult 
TS mouse [10, 22]. These beneficial effects of melatonin in TS animals were partially due to the 
prevention of cholinergic degeneration and to the normalization of the function and/or morphology 
of the hippocampus. In this study, we evaluated other mechanisms that could be involved in the 
altered cognition of these mice, i.e., the oxidative stress status and the density of senescent cells 
in the brain, as well as the effect of melatonin treatment on these processes. 
We first evaluated the status of the antioxidant defense system in the brain of TS and CO mice. 
Consistent with the triplication of the Sod1 gene and the increased activity of SOD observed in 
different tissues in DS individuals and TS mice [15, 23, 26, 27], we found that SOD activity was 
increased in the cortex and hippocampus of TS mice. Although SOD catalyzes the dismutation of 
superoxide, a free radical with high toxicity, to non-radical molecules such as oxygen and H2O2, 
the accumulation of H2O2 or its inefficient removal, leads to the  formation of the most deleterious 
hydroxyl radical (HO-) that damage membrane lipids, proteins and other biomolecules [28]. Thus, 
the increase activity of SOD found in the brain of TS mice may lead to an excess of OH- 
production resulting in high oxidative damage. 
To prevent the accumulation of H2O2, SOD activity must be balanced with GPx and CAT 
activities. In DS neurons, higher SOD activity without the concomitant increase of complementary 
antioxidant enzymes activities, CAT and GPx, create a redox imbalance that may not efficiently 
neutralize the excess of H2O2 [29]. In this study, while GPx activity was increased in the cortex 
and hippocampus, CAT activity was only increased in the cortex of TS mice. The increase in GPx 
activity found in the brains of TS mice may be due to induction of the enzyme by excess H2O2 and 
lipid peroxides as an adaptative response to oxidative stress [30]. However, the fact that CAT 



































































activity could result in insufficient removal of H2O2, which would favor the generation of HO-; this, 
in turn, could produce persistent oxidative stress. 
Among the anti-oxidative stress-related enzymes, GST acts in xenobiotic detoxification by 
catalyzing the conjugation of GSH to chemical toxins [31] and contributing to the detoxification of 
the endogenous hydroperoxides that are continuously generated through cellular lipoperoxidation 
processes [32]. In agreement with previous observations in the blood of DS subjects [27, 31], in 
this study, the activity of the GST enzyme in the hippocampus of TS mice was lower than that in 
CO mice. Considering the antioxidant effects of this enzyme [31], this may be an additional factor 
contributing to the oxidative damage in this structure in this model of DS. 
The levels of GSH, another major neuronal endogenous antioxidant, are reduced in DS subjects 
[27, 31]. Consistent with previous studies [33], we found no differences in the brain activity of GR 
(a central player in the conversion of GSSH to GSH) between CO and TS mice. However, the 
levels of GSH also depend on the levels of γ-glutamylcysteine synthase and glucose-6-phosphate 
dehydrogenase [34] that were not measured in our study. 
Melatonin has been shown to reduce oxidative stress through different mechanisms [21, 34, 35]: 
indirectly, by modulating the activity of the enzymes that are involved in controlling oxidative 
processes (up-regulating antioxidant and down-regulating pro-oxidant enzymes); and directly, by 
acting as a free radical scavenger and interacting with oxidative radicals. 
In this study, chronic melatonin treatment did not modify the activity of SOD, CAT, GPx, GR or 
GST enzymes, suggesting that melatonin does not exert its antioxidant effects in the brains of 
adult TS mice by regulating the antioxidant defense system. This lack of effect of melatonin to 
modulate the indirect mechanism to reduce oxidative stress in TS mice might be due to the fact 
that the ability of this indoleamine to detoxify free radicals is highly variable and depends on the 



































































melatonin administration to a mouse model of AD diminish the mRNA expression levels of the 
antioxidant enzymes SOD, CAT and GPx. However, a previous study in another model of AD 
reported opposite effects of melatonin treatment on antioxidant enzymes [38]. In TS mice, the 
genetically predetermined increase in SOD activity induces a dysregulation of the other two 
enzymes and other triplicated genes also influence the redox-metabolism [39]. These factors are 
likely to be contributing to the divergent results found after melatonin administration in the 
expression levels of these enzymes in TS mice and in murine models of AD. Furthermore, the 
regulation of antioxidant enzymes by melatonin can be also different depending upon under basal 
or elevated oxidative stress conditions [34] as occur in the brain of TS mice. 
Melatonin can also contribute to neuroprotection exerting other indirect antioxidative and pro-
survival effects by regulating different anti- or pro- apoptotic proteins and enzyme cofactors [40, 
41]. In addition, melatonin also modulates a broad set of ROS- and survival-related signaling 
pathways that implicate transcriptional factors, such as NF-κB or Akt [42- 44], that activate 
different pro-inflammatory genes involved in age-related processes under increased oxidative 
stress. Future studies should explore the effects of melatonin administration in these signaling 
pathways in TS mice. 
Lipids and proteins are the molecules that are most prone to undergo major oxidative injury. 
Therefore, we measured the levels of oxidative damage in proteins and lipids in the brains of TS 
mice. Consistent with previous studies in DS individuals and TS mice in which other markers of 
oxidative stress were analyzed [10, 12], the levels of TBARS and PC were increased in the 
hippocampus, but not in the cortex, of vehicle-treated TS mice. These findings suggest that in 
adult TS mice, cells in the cortex may exhibit greater tolerance or better regulation against 
oxidative stress than in the hippocampus. Further support for this hypothesis comes from the 
finding that the activity of CAT and GPx was also increased in the cortex of TS mice. These 



































































of ROS and of oxidative injury in the cortex. Conversely, an imbalance of these enzymes in the 
hippocampus would lead to increased oxidative stress in this structure, which could play a role in 
the cognitive deficits and neurogenesis alterations that have previously been described in this 
model of DS [4]. Therefore, further studies are needed to determine whether brain structure-
specific manipulations of the levels of the SOD and catalase enzymes, may account for the 
higher vulnerability of hippocampus to suffer oxidative stress damage. 
The second mechanism by which melatonin reduces oxidative damage is its direct ROS 
scavenging properties [21], detoxifying a variety of free radicals and reactive oxygen 
intermediates, including OH-, peroxynitrite anion, singlet oxygen and nitric oxide [45] to avoid 
oxidative damage. In this study we showed that melatonin treatment rescued the levels of protein 
damage and lipid peroxidation in the hippocampus of TS mice because they did not differ from 
those of CO mice, indicating that the main antioxidant action of this indoleamine in this mouse 
model of DS may be due to its action as a free radical scavenger. This protective effect of 
melatonin against lipid and protein damage is consistent with previous reports in other mouse 
models with different neuropathologies [20, 38] or with brain damage induced by radiation or by 
toxin exposure [46, 47] in which oxidative stress plays an important role. 
In addition, oxidative stress is an important factor that causes cell senescence [14, 15, 25]. 
Because the hippocampus of TS mice seems to be exposed to greater amounts of oxidative 
stress, we analyzed the density of senescent cells in this structure. We found that vehicle-treated 
TS mice showed a higher density of SA-β-gal-positive cells in the DG of the hippocampus than 
CO mice. Consistent with these findings, it was recently demonstrated that fibroblasts with 




































































Interestingly, melatonin normalized the density of SA-β-gal-positive cells in TS mice to a level 
comparable to the one found in vehicle-treated CO mice, indicating a potential antiaging 
protective effect in the hippocampus of this model. These results are consistent with previous 
studies that showed that melatonin treatment effectively reverses H2O2-induced senescent 
phenotypes in mesenchymal stem cells [14]. Thus, it is likely that the melatonin-induced 
antioxidant effects in the hippocampus of TS mice may be involved in the reduction of senescent 
cells in this structure. 
Although administration of the antioxidant analogue of the nootropic piracetam SGS-111 from 
conception or during adulthood failed to improve cognition in the TS mouse [48], other 
antioxidants, such as vitamin E, normalize oxidative stress and delay impairments in cognitive 
performance [11]. It has been demonstrated that, due to a variety of physiological and metabolic 
advantages [35], the protective effects of melatonin against oxidative damage are more potent 
than the ones induced by vitamins C or E [21], partially because the metabolites formed by free 
radical scavenging also present antioxidant activity [21, 35]. Because the pro-cognitive effects of 
melatonin are related to its multiple antioxidant actions [20, 37, 46, 47] and the learning and 
memory deficits in TS mice are associated with increased brain oxidative stress, our results 
suggests that the beneficial effects found in TS mice cognition after melatonin treatment [22] 
could be partially due to its antioxidant action as a ROS scavenger. 
However, because melatonin has been also demonstrated to exert other neuroprotective effects, 
its administration could improve cognition by other mechanisms such as recovering LTP or 
promoting neurogenesis [19, 20, 49-51]. In our previous work [10], melatonin also decreased 
cholinergic degeneration, increased the density of proliferating cells, of differentiated neuroblast 
and of mature granular cells and improved the impaired LTP in the hippocampus of the TS mice. 
And, in the present study, melatonin also reduced the density of cells with a senescent phenotype 



































































also be due to other neuroprotective actions. Therefore, melatonin could be a more effective 
pharmacological tool to reduce several DS-altered phenotypes than other antioxidants due to its 
multiple effects. 
Conclusions 
In summary (see Fig. 4), the results of the present study revealed an enhanced pro-oxidant status 
in the hippocampus of adult TS mice. This persistent oxidative state may account for the higher 
density of cells with a senescent phenotype that was demonstrated for the first time in the 
hippocampus of TS mice. Melatonin administration exerted antioxidant effects in the 
hippocampus of TS animals that were apparently not mediated by regulation of the activity of the 
antioxidant defense system but by the effects of melatonin as a ROS scavenger, which led to 
attenuation of the levels of oxidative damage. In addition, melatonin exerted an antiaging effect, 
as demonstrated by a reduction in the density of senescent cells in the hippocampus of TS mice. 
The present results provide further support for the neuroprotective effects of melatonin 
administration to adult TS animals and suggest that melatonin could be a potential beneficial 
supplement for the treatment of the age-related cognitive decline in DS individuals. 
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Fig. 1. Mean ± S.E.M. of the levels of PC (A) and TBARS (B) in the cortex and hippocampus of 
TS and CO mice treated with melatonin or vehicle. *p<0.05, TS vs. CO; #p<0.05; ##p<0.01; 
###p<0.001, vehicle-treated vs. melatonin-treated mice. p values reflect the outcomes of post hoc 
tests following a Bonferroni correction performed after MANOVAs. 
Fig. 2. Mean ± S.E.M. of the activity levels of different antioxidant enzymes in the hippocampus 
and cortex of TS and CO mice treated with melatonin or vehicle. Superoxide dismutase (SOD, A), 
catalase (CAT, B), glutathione peroxidase (GPx, C), glutathione reductase (GR, D), and 
glutathione S-transferase (GST, E). Mean ± SEM. *p<0.05; **p<0.01; ***p<0.001 TS vs. CO. p 
values reflect the outcomes of post hoc tests following a Bonferroni correction performed after 
MANOVAs. 
Fig. 3. Representative photomicrographs of SA-β-gal-stained sections (A) and mean ± S.E.M. of 
the density of β-gal-positive cells (B) of the SGZ of the hippocampus of TS and CO mice treated 
with melatonin or vehicle. *p<0.05; TS vs. CO; #p<0.05; melatonin vs. vehicle. p values reflect the 
outcomes of post hoc tests following a Bonferroni correction performed after MANOVAs. 
Fig. 4. Schematic diagram summarizing the differences in the brain oxidative status between TS 
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